Form
"*" indicates required fields
Bulk and Custom Quotation Request
If you need a product to meet a specific quality requirement, bulk quantity or packaging formats, Please use this form to request price and lead time.
"*" indicates required fields
Form
Biopharmaceutical Solutions
Biopharmaceutical Solutions
ILC Dover is a global supplier of flexible, single-use systems and aseptic solutions that support upstream and downstream biopharma manufacturing processes.
Our custom solutions for biopharmaceutical manufacturing are engineered and manufactured in our ISO 7 Clean Room and designed for the efficient, sterile handling and transport of large volumes of organic compounds. Beyond that, our flexible aseptic containment solutions reduce bottlenecks by providing closed, Grade-A, aseptic environments for efficient fill/finish activities. Explore how our single-use biopharma solutions support upstream processing and downstream processing from buffer, media, acid, and base transport to aseptic fill/finish operations.
Water for Injection (WFI) Quality Water
ILC Dover’s WFI Quality Water is produced in a cGMP-compliant, US-based facility and meets monographs for USP, Ph. Eur., and JP. Through a distillation still combined with upstream processing and 0.1 μm filtration, intrinsically safe WFI is created with significantly less risk than other production methods.
Which Industry are you interested in?
Choose a segment to explore our solutions.
Fill/Finish Manufacturing
We help biopharmaceutical manufacturing professionals complete fill/finish processes through disposable processing systems and prefilled, trust-weighted cGMP chemicals for biopharma.
Learn More
Custom Solutions for Biopharmaceutical Contract Manufacturing
The ArmorFlex® Family of Films is the premier single-use system for biopharmaceuticals. ArmorFlex® Films are designed and proven to provide unmatched performance and increase handling speed and safety.
ILC Dover Acquires Solo Containment
Our recent acquisition of Solo Containment has expanded our custom solutions to include aseptic flexible isolators and other flexible film containment isolators, targeting niche HPAPI applications for biopharma processing systems.
